William G. Harris - Oct 29, 2021 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Director
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Stock symbol
SLNO
Transactions as of
Oct 29, 2021
Transactions value $
-$4,740
Form type
4
Date filed
11/2/2021, 04:47 PM
Previous filing
Aug 3, 2021
Next filing
Feb 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Award $0 +20.2K +22.2% $0.00 111K Oct 29, 2021 Direct F1
transaction SLNO Common Stock Tax liability -$4.74K -6.37K -5.74% $0.74 105K Oct 29, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of SLNO common stock. The RSUs are fully vested on October 29, 2021.
F2 Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person.